The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Randomized multicenter trial of 3 weekly cabazitaxel versus weekly paclitaxel chemotherapy in the first-line treatment of HER2 negative metastatic breast cancer (MBC).
 
Amit Bahl
Honoraria - Bayer; BMS; Merck; Pfizer; Roche; Sanofi/Aventis
Research Funding - Janssen (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Bayer; Roche
 
Jeremy Braybrooke
Consulting or Advisory Role - Healthcare at Home
 
Alicia Bravo
Research Funding - Janssen (Inst); Sanofi (Inst)
 
Emily Foulstone
Research Funding - Janssen (Inst); Sanofi (Inst)
 
Jessica Ball
No Relationships to Disclose
 
Mark Churn
No Relationships to Disclose
 
Sidharth Dubey
No Relationships to Disclose
 
Saiqa Spensley
Consulting or Advisory Role - Lilly; Pfizer; Roche
Travel, Accommodations, Expenses - Roche
 
Rebecca Bowen
Honoraria - GlaxoSmithKline
Consulting or Advisory Role - AstraZeneca; Clovis Oncology
 
Simon Waters
No Relationships to Disclose
 
Pippa Riddle
No Relationships to Disclose
 
Duncan Wheatley
Honoraria - AstraZeneca; Lilly; Novartis; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Lilly; Novartis; Pfizer; Roche
Speakers' Bureau - AstraZeneca; Lilly; Novartis; Pfizer; Roche
Travel, Accommodations, Expenses - Roche
 
Peter Stephens
No Relationships to Disclose
 
Janine Mansi
No Relationships to Disclose
 
Pavel Bezecny
Consulting or Advisory Role - Lilly
 
Srinivasan Madhusudan
No Relationships to Disclose
 
Mark Verrill
Stock and Other Ownership Interests - Bayer; Roche
Honoraria - AstraZeneca; Daiichi Sankyo; Exact Sciences; Lilly; Novartis; Pfizer; Roche
Consulting or Advisory Role - Daiichi Sankyo; Exact Sciences; Lilly; Merck; Novartis; Pfizer; Roche
Speakers' Bureau - Lilly
Research Funding - Amgen (Inst); Aventis Pharma (Inst); Exact Sciences (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Exact Sciences; Lilly; Roche
 
Alison Markham
No Relationships to Disclose
 
Sylvia Pearson
No Relationships to Disclose
 
William Wilson
No Relationships to Disclose